Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Vigil Neuroscience, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 35 | −11 |
| Shares | 17.9M | 2.45K | 17.3M | −515.0K (−2.9%) |
| Value | $125.1M | $17.0K | $44.6M | −$80.5M (−64.4%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 130,200 | $336.0K | 0.01% |
| Adage Capital Partners GP, L.L.C. | 22,269 | $57.0K | 0.00% |
| Cannell Capital LLC | 3,636 | $9.00K | 0.00% |
| FMR LLC | 40 | $0 | 0.00% |
| Credit Suisse AG | 4 | $0 | 0.00% |
| PEAK6 Investments LLC | 14,337 | – | – |
Sold out (17)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Squarepoint Ops LLC | 86,193 | $606.0K |
| Caas Capital Management LP | 75,000 | $527.0K |
| Davidson Kempner Capital Management LP | 30,000 | $211.0K |
| Millennium Management LLC | 19,930 | $140.0K |
| Charles Schwab Investment Management Inc | 19,198 | $135.0K |
| Bank of New York Mellon Corp | 13,341 | $94.0K |
| Deutsche Bank AG | 3,747 | $26.0K |
| American International Group, Inc. | 3,332 | $23.0K |
| California State Teachers Retirement System | 2,795 | $20.0K |
| Amalgamated Bank | 2,451 | $17.0K |
| Tower Research Capital LLC (TRC) | 1,773 | $12.0K |
| Bank of America Corp | 1,519 | $11.0K |
| STRS Ohio | 1,600 | $11.0K |
| Royal Bank of Canada | 1,037 | $7.00K |
| Legal & General Group Plc | 634 | $4.00K |
| Ameritas Investment Partners, Inc. | 500 | $4.00K |
| High Net Worth Advisory Group LLC | 500 | $4.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,451 | $17.0K |